New York State Teachers Retirement System Cuts Stock Position in Bath & Body Works, Inc. $BBWI

New York State Teachers Retirement System lessened its position in shares of Bath & Body Works, Inc. (NYSE:BBWI) by 13.2% in the 1st quarter, HoldingsChannel reports. The fund owned 203,047 shares of the company’s stock after selling 30,900 shares during the period. New York State Teachers Retirement System’s holdings in Bath & Body Works were worth $3,791,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors also recently bought and sold shares of the company. Chase Investment Counsel Corp acquired a new position in shares of Bath & Body Works during the fourth quarter worth $1,606,000. SG Americas Securities LLC raised its stake in Bath & Body Works by 725.3% in the fourth quarter. SG Americas Securities LLC now owns 466,338 shares of the company’s stock valued at $9,364,000 after buying an additional 409,831 shares during the last quarter. Wedge Capital Management L L P NC raised its stake in Bath & Body Works by 49.9% in the fourth quarter. Wedge Capital Management L L P NC now owns 214,362 shares of the company’s stock valued at $4,304,000 after buying an additional 71,349 shares during the last quarter. Vaughan Nelson Investment Management L.P. boosted its holdings in Bath & Body Works by 27.4% in the fourth quarter. Vaughan Nelson Investment Management L.P. now owns 2,132,245 shares of the company’s stock worth $42,815,000 after acquiring an additional 458,620 shares in the last quarter. Finally, Intech Investment Management LLC boosted its holdings in Bath & Body Works by 462.6% in the fourth quarter. Intech Investment Management LLC now owns 108,766 shares of the company’s stock worth $2,184,000 after acquiring an additional 89,432 shares in the last quarter. Hedge funds and other institutional investors own 95.14% of the company’s stock.

Bath & Body Works Stock Down 5.8%

Bath & Body Works stock opened at $19.41 on Thursday. The firm has a market cap of $3.91 billion, a price-to-earnings ratio of 5.45, a price-to-earnings-growth ratio of 2.04 and a beta of 1.38. Bath & Body Works, Inc. has a 52 week low of $14.27 and a 52 week high of $33.96. The business’s 50-day moving average price is $19.46 and its 200 day moving average price is $20.41.

Bath & Body Works (NYSE:BBWI) last released its quarterly earnings data on Wednesday, May 27th. The company reported $0.32 EPS for the quarter, topping the consensus estimate of $0.29 by $0.03. The business had revenue of $1.38 billion for the quarter, compared to analyst estimates of $1.36 billion. Bath & Body Works had a negative return on equity of 45.34% and a net margin of 10.03%.The business’s quarterly revenue was down 3.2% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $0.49 EPS. Bath & Body Works has set its Q2 2026 guidance at 0.300-0.300 EPS and its FY 2026 guidance at 2.400-2.650 EPS. Equities analysts expect that Bath & Body Works, Inc. will post 2.63 EPS for the current year.

Bath & Body Works Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Friday, June 19th. Investors of record on Friday, June 5th were given a dividend of $0.20 per share. This represents a $0.80 annualized dividend and a yield of 4.1%. The ex-dividend date was Friday, June 5th. Bath & Body Works’s dividend payout ratio (DPR) is currently 22.47%.

Analyst Upgrades and Downgrades

Several research firms have recently issued reports on BBWI. Barclays cut their price objective on shares of Bath & Body Works from $25.00 to $23.00 and set an “equal weight” rating on the stock in a report on Thursday, May 28th. TD Cowen upped their price target on shares of Bath & Body Works from $20.00 to $25.00 and gave the company a “buy” rating in a research note on Thursday, May 28th. Weiss Ratings cut shares of Bath & Body Works from a “hold (c-)” rating to a “sell (d+)” rating in a report on Tuesday, June 2nd. The Goldman Sachs Group downgraded shares of Bath & Body Works from a “neutral” rating to a “sell” rating and lowered their price objective for the stock from $23.00 to $19.00 in a research note on Wednesday. Finally, UBS Group dropped their price objective on shares of Bath & Body Works from $22.00 to $19.00 and set a “neutral” rating on the stock in a report on Wednesday, May 20th. Three equities research analysts have rated the stock with a Buy rating, thirteen have issued a Hold rating and two have given a Sell rating to the company. According to data from MarketBeat.com, Bath & Body Works presently has an average rating of “Hold” and a consensus price target of $22.00.

Bath & Body Works Company Profile

Bath & Body Works, Inc is a leading specialty retailer focused on personal care, home fragrance and complementary products. Through its flagship Bath & Body Works brand, the company offers a diverse assortment of shower gels, lotions, fragrance mists, candles and home fragrance items. Its product portfolio also includes the White Barn Candle Co range of premium scented candles and diffusers. Bath & Body Works serves consumers through a combination of brick-and-mortar stores and e-commerce platforms, delivering seasonal collections, limited-edition releases and signature scent lines.

Founded in 1990 as part of Limited Brands (now L Brands), Bath & Body Works opened its first store in New Albany, Ohio, and quickly expanded across the United States.